MedTrace Logo

Hearing Screening in Adults Over 50 Years Old

NCT06894927 · Status: ENROLLING_BY_INVITATION · Phase: NA · Type: INTERVENTIONAL · Enrollment: 330

Last updated 2025-05-30

No results posted yet for this study

Summary

The goal of this single-arm quasi-experimental study is to evaluate the feasibility, effectiveness, and management of three different hearing screening methods in adults aged 50 years and older in the Czech Republic. The main questions it aims to answer are:

Are the selected hearing screening methods effective in detecting hearing loss in the target population? Can these methods be successfully implemented within the national healthcare system to address gaps in current practices?

Participants will:

1. Undergo hearing screening using all three methods, conducted by general practitioners, to assess their performance.
2. Complete follow-up evaluations conducted by ENT specialists to confirm diagnostic results.

Conditions

  • Hearing Loss, Bilateral Sensorineural, Progressive
  • Hearing Loss, Bilateral (Causes Other Than Tumors)
  • Hearing Loss, Bilateral or Unilateral
  • Presbyacusis

Interventions

DIAGNOSTIC_TEST

Screening HHIA questionnaire

Completion of the abbreviated (screening) version of the standardized "HHIA" questionnaire (Czech version).

DIAGNOSTIC_TEST

Whispered voice test

Whispered voice test conducted following the standardized protocol.

DIAGNOSTIC_TEST

Screening pure tone audiometry

Screening pure-tone audiometry at a level of 35 dB at the frequencies: 500, 1000, 2000, and 4000 Hz.

DIAGNOSTIC_TEST

Pure Tone Audiometry

Clinical Pure Tone Audiometry

DIAGNOSTIC_TEST

Tympanometry

Clinical Tympanometry

Sponsors & Collaborators

  • The Society of General Practice, J. E. Purkyne Czech Medical Association

    collaborator UNKNOWN

  • Hospital Pardubice

    collaborator UNKNOWN

  • University Hospital Hradec Kralove

    lead OTHER

Principal Investigators

  • Viktor Chrobok, prof., M.D., CSc., Ph.D. · University Hospital Hradec Kralove

  • MUDr. Michal Homoláč · University Hospital Hradec Kralove

Study Design

Allocation
NA
Purpose
SCREENING
Masking
NONE
Model
SINGLE_GROUP

Eligibility

Min Age
50 Years
Sex
ALL
Healthy Volunteers
Yes

Timeline & Regulatory

Start
2025-01-01
Primary Completion
2025-06-30
Completion
2025-06-30

Countries

  • Czechia

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT06894927 on ClinicalTrials.gov